Li‐Ping Ge

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0002-3578-0073

发表论文 49 篇 · 总被引 1069 次 · h-index 15

代表论文

• Comprehensive metabolomics expands precision medicine for triple-negative breast cancer (2022 · Cell Research · 被引 338)
• LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer (2020 · Molecular Cancer · 被引 94)
• SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer (2020 · Theranostics · 被引 55)
• ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer (2024 · Cell Research · 被引 44)
• DNAzyme-based faithful probing and pulldown to identify candidate biomarkers of low abundance (2023 · Nature Chemistry · 被引 44)
• Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor (2021 · Oncogene · 被引 29)